{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:53:38Z","timestamp":1791273218338,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06225-9","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:30:43Z","timestamp":1791271843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Systematic Review of Stem Cell Secretome\u2013Derived Exosomes for Neuropathic Pain: Therapeutic Mechanisms and Translational Potential"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9833-1909","authenticated-orcid":false,"given":"Aidin","family":"Shahrezaei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6285-1036","authenticated-orcid":false,"given":"Farinaz","family":"Nasirinezhad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"6225_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108546","volume":"251","author":"M Thouaye","year":"2023","unstructured":"Thouaye M, Yalcin I (2023) Neuropathic pain: from actual pharmacological treatments to new therapeutic horizons. Pharmacol Ther 251:108546. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108546","journal-title":"Pharmacol Ther"},{"key":"6225_CR2","doi-asserted-by":"publisher","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014 Apr;155(4):654\u2013662. https:\/\/doi.org\/10.1016\/j.pain.2013.11.013. Epub 2013 Nov 26. Erratum in: Pain. 2014 Sep;155(9):1907","DOI":"10.1016\/j.pain.2013.11.013"},{"issue":"2","key":"6225_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/PR9.0000000000001066","volume":"8","author":"G Baskozos","year":"2023","unstructured":"Baskozos G, H\u00e9bert HL, Pascal MM, Themistocleous AC, Macfarlane GJ, Wynick D, Bennett DL, Smith BH (2023) Epidemiology of neuropathic pain: an analysis of prevalence and associated factors in UK Biobank. Pain Rep 8(2):e1066. https:\/\/doi.org\/10.1097\/PR9.0000000000001066","journal-title":"Pain Rep"},{"issue":"1","key":"6225_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1152\/physrev.00045.2019","volume":"101","author":"NB Finnerup","year":"2021","unstructured":"Finnerup NB, Kuner R, Jensen TS (2021) Neuropathic pain: from mechanisms to treatment. Physiol Rev 101(1):259\u2013301. https:\/\/doi.org\/10.1152\/physrev.00045.2019","journal-title":"Physiol Rev"},{"key":"6225_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","volume":"32","author":"M Costigan","year":"2009","unstructured":"Costigan M, Scholz J, Woolf CJ (2009) Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 32:1\u201332. https:\/\/doi.org\/10.1146\/annurev.neuro.051508.135531","journal-title":"Annu Rev Neurosci"},{"key":"6225_CR6","doi-asserted-by":"publisher","unstructured":"Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanp\u00e4\u00e4 M, et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14(2):162\u201373. https:\/\/doi.org\/10.1016\/S1474-4422(14)70251-0. Epub 2015 Jan 7","DOI":"10.1016\/S1474-4422(14)70251-0"},{"issue":"13","key":"6225_CR7","doi-asserted-by":"publisher","first-page":"1536566","DOI":"10.3389\/fcell.2025.1536566","volume":"21","author":"WJ Zhang","year":"2025","unstructured":"Zhang WJ, Pi XW, Hu DX, Liu XP, Wu MM (2025) Advances and challenges in cell therapy for neuropathic pain based on mesenchymal stem cells. Front Cell Dev Biol 21(13):1536566. https:\/\/doi.org\/10.3389\/fcell.2025.1536566","journal-title":"Front Cell Dev Biol"},{"key":"6225_CR8","doi-asserted-by":"publisher","DOI":"10.34172\/bi.30648","volume":"15","author":"A Shahrezaei","year":"2025","unstructured":"Shahrezaei A, Sohani M, Nasirinezhad F (2025) Mesenchymal stem cells as a therapeutic strategy to combat oxidative stress-mediated neuropathic pain. Bioimpacts 15:30648. https:\/\/doi.org\/10.34172\/bi.30648","journal-title":"Bioimpacts"},{"issue":"1","key":"6225_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04826-0","volume":"16","author":"L Xia","year":"2025","unstructured":"Xia L, Qin J, Ye S (2025) Addressing the challenges of immunogenicity, heterogeneity and tumorigenicity in the clinical translation of human embryonic stem cells. Stem Cell Res Ther 16(1):694. https:\/\/doi.org\/10.1186\/s13287-025-04826-0","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"6225_CR10","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s12013-024-01410-w","volume":"82","author":"Z Jaleh","year":"2024","unstructured":"Jaleh Z, Rahimi B, Shahrezaei A, Sohani M, Sagen J, Nasirinezhad F (2024) Exploring the therapeutic potential of mesenchymal stem cells-derived conditioned medium: an in-depth analysis of pain alleviation, spinal CCL2 levels, and oxidative stress. Cell Biochem Biophys 82(3):2977\u20132988. https:\/\/doi.org\/10.1007\/s12013-024-01410-w","journal-title":"Cell Biochem Biophys"},{"issue":"20","key":"6225_CR11","doi-asserted-by":"publisher","first-page":"15901","DOI":"10.2147\/IJN.S573168","volume":"28","author":"X Li","year":"2025","unstructured":"Li X, Wang C, Du K, Wang J, Lin J, Yang C (2025) Mesenchymal stem cell-derived exosomes: a promising therapeutic strategy for spinal cord injury. Int J Nanomedicine 28(20):15901\u201315920. https:\/\/doi.org\/10.2147\/IJN.S573168","journal-title":"Int J Nanomedicine"},{"key":"6225_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1142088","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Zhang M, Liao Y, Chen H, Su D, Tao Y, Li J, Luo K, et al. (2023) Human umbilical cord mesenchymal stem cell-derived exosomes promote murine skin wound healing by neutrophil and macrophage modulations revealed by single-cell RNA sequencing. Front Immunol 14:1142088. https:\/\/doi.org\/10.3389\/fimmu.2023.1142088","journal-title":"Front Immunol"},{"key":"6225_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1625943","volume":"18","author":"Z Wei","year":"2025","unstructured":"Wei Z, Guo C, Zhou H, Wu Y, Zhou X, Chen J, Li F (2025) Exosome-mediated miRNA delivery: a molecular switch for reshaping neuropathic pain therapy. Front Mol Neurosci 18:1625943. https:\/\/doi.org\/10.3389\/fnmol.2025.1625943","journal-title":"Front Mol Neurosci"},{"key":"6225_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115507","volume":"395","author":"Y Xu","year":"2025","unstructured":"Xu Y, Wang S, Li Z, Wang J, Wang M, Xue Q, Tao J, Huang S, et al. (2025) Bone marrow mesenchymal stem cell-derived exosomes alleviate neuropathic pain after spinal cord injury by inhibiting the TLR4\/MyD88\/NF-\u03baB pathway. Exp Neurol 395:115507. https:\/\/doi.org\/10.1016\/j.expneurol.2025.115507","journal-title":"Exp Neurol"},{"key":"6225_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/17448069261417109","volume":"22","author":"L Yang","year":"2026","unstructured":"Yang L, Yang B, Xue Y, Fang J, Cui C (2026) Mechanism of human umbilical cord mesenchymal stem cell-derived exosomes in alleviating neuropathic pain in CCI rats. Mol Pain 22:17448069261417109. https:\/\/doi.org\/10.1177\/17448069261417109","journal-title":"Mol Pain"},{"issue":"18","key":"6225_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813946","volume":"24","author":"E Garcia","year":"2023","unstructured":"Garcia E, Buzoianu-Anguiano V, Silva-Garcia R, Esparza-Salazar F, Arriero-Caba\u00f1ero A, Escandon A, Doncel-P\u00e9rez E, Ibarra A (2023) Use of cells, supplements, and peptides as therapeutic strategies for modulating inflammation after spinal cord injury: an update. Int J Mol Sci 24(18):13946. https:\/\/doi.org\/10.3390\/ijms241813946","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6225_CR17","doi-asserted-by":"publisher","first-page":"1625787","DOI":"10.3389\/fmed.2025.1625787","volume":"18","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhu J, Ma Q, Zhou W, Yang L, Sheng S, Zhu F, Xia Z (2025) Trends in mesenchymal stem cell-derived extracellular vesicles clinical trials 2014\u20132024: is efficacy optimal in a narrow dose range? Front Med (Lausanne) 18(12):1625787. https:\/\/doi.org\/10.3389\/fmed.2025.1625787","journal-title":"Front Med (Lausanne)"},{"key":"6225_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1131536","volume":"15","author":"K Zhang","year":"2023","unstructured":"Zhang K, Li P, Jia Y, Liu M, Jiang J (2023) Concise review: current understanding of extracellular vesicles to treat neuropathic pain. Front Aging Neurosci 15:1131536. https:\/\/doi.org\/10.3389\/fnagi.2023.1131536","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"6225_CR19","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3390\/ijms27052397","volume":"27","author":"ZH Harun","year":"2026","unstructured":"Harun ZH, Ng MH, Mohamed Haflah NH, Ohnmar H, Lokanathan Y, Law ZK, Naicker AS, Thow SY, et al. (2026) Systematic review: preclinical and clinical evidence on MSC efficacy and mechanism of action in neuropathic pain reduction. Int J Mol Sci 27(5):2397. https:\/\/doi.org\/10.3390\/ijms27052397","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6225_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11916-024-01331-6","volume":"29","author":"S Kataria","year":"2025","unstructured":"Kataria S, Inggas MAM, Patel U, Wijaya JH, Yabut K, Ayub MA, Maniyar P, Upadhyay N, et al. (2025) A systematic review and meta-analysis of stem cell therapies for pain in diabetic neuropathy, osteoarthritis, and spinal cord injuries. Curr Pain Headache Rep 29(1):29. https:\/\/doi.org\/10.1007\/s11916-024-01331-6","journal-title":"Curr Pain Headache Rep"},{"key":"6225_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.26633\/RPSP.2022.112","volume":"30","author":"MJ Page","year":"2022","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, et al. (2022) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Panam Salud Publica 30:46. https:\/\/doi.org\/10.26633\/RPSP.2022.112","journal-title":"Rev Panam Salud Publica"},{"key":"6225_CR22","doi-asserted-by":"publisher","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, Thomas J (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 10(10) ED000142. https:\/\/doi.org\/10.1002\/14651858.ED000142","DOI":"10.1002\/14651858.ED000142"},{"key":"6225_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"6225_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4","journal-title":"Syst Rev"},{"key":"6225_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43. https:\/\/doi.org\/10.1186\/1471-2288-14-43","journal-title":"BMC Med Res Methodol"},{"key":"6225_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, et al. (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"6225_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, et al. (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"issue":"13","key":"6225_CR28","doi-asserted-by":"publisher","first-page":"1655623","DOI":"10.3389\/fcell.2025.1655623","volume":"13","author":"NM Mussin","year":"2025","unstructured":"Mussin NM, Zhilisbayeva KR, Baspakova A, Kurmanalina MA, Tamadon A (2025) Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions. Front Cell Dev Biol 13(13):1655623. https:\/\/doi.org\/10.3389\/fcell.2025.1655623","journal-title":"Front Cell Dev Biol"},{"key":"6225_CR29","doi-asserted-by":"publisher","unstructured":"Fan B, Chopp M, Zhang ZG, Liu XS (2021) Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol 341 113694. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113694","DOI":"10.1016\/j.expneurol.2021.113694"},{"issue":"1","key":"6225_CR30","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/j.pain.0000000000001395","volume":"160","author":"SJ Shiue","year":"2019","unstructured":"Shiue SJ, Rau RH, Shiue HS, Hung YW, Li ZX, Yang KD, Cheng JK (2019) Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats. Pain 160(1):210\u2013223. https:\/\/doi.org\/10.1097\/j.pain.0000000000001395","journal-title":"Pain"},{"issue":"13","key":"6225_CR31","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.2147\/JPR.S286771","volume":"4","author":"JM Hsu","year":"2020","unstructured":"Hsu JM, Shiue SJ, Yang KD, Shiue HS, Hung YW, Pannuru P, Poongodi R, Lin HY, et al. (2020) Locally applied stem cell exosome-scaffold attenuates nerve injury-induced pain in rats. J Pain Res 4(13):3257\u20133268. https:\/\/doi.org\/10.2147\/JPR.S286771","journal-title":"J Pain Res"},{"key":"6225_CR32","doi-asserted-by":"publisher","first-page":"109505","DOI":"10.1016\/j.intimp.2022.109505","volume":"114","author":"X Gao","year":"2023","unstructured":"Gao X, Gao LF, Zhang YN, Kong XQ, Jia S, Meng CY (2023) Huc-MSCs-derived exosomes attenuate neuropathic pain by inhibiting activation of the TLR2\/MyD88\/NF-\u03baB signaling pathway in the spinal microglia by targeting Rsad2. Int Immunopharmacol 114:109505. https:\/\/doi.org\/10.1016\/j.intimp.2022.109505","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"6225_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/0001-3765202220210564","volume":"94","author":"YU Zhang","year":"2022","unstructured":"Zhang YU, Ye G, Zhao J, Chen Y, Kong L, Sheng C, Yuan L (2022) Exosomes carried miR-181c-5p alleviates neuropathic pain in CCI rat models. An Acad Bras Cienc 94(3):e20210564. https:\/\/doi.org\/10.1590\/0001-3765202220210564","journal-title":"An Acad Bras Cienc"},{"issue":"1","key":"6225_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s10020-022-00561-x","volume":"28","author":"S Li","year":"2022","unstructured":"Li S, Huang C, Tu C, Chen R, Ren X, Qi L, Li Z (2022) Bone marrow mesenchymal stem cell-derived exosomes shuttling miR-150-5p alleviates mechanical allodynia in rats by targeting NOTCH2 in microglia. Mol Med 28(1):133. https:\/\/doi.org\/10.1186\/s10020-022-00561-x","journal-title":"Mol Med"},{"issue":"1","key":"6225_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02578-9","volume":"19","author":"Y Lu","year":"2022","unstructured":"Lu Y, Zhang J, Zeng F, Wang P, Guo X, Wang H, Qin Z, Tao T (2022) Human PMSCs-derived small extracellular vesicles alleviate neuropathic pain through miR-26a-5p\/Wnt5a in SNI mice model. J Neuroinflammation 19(1):221. https:\/\/doi.org\/10.1186\/s12974-022-02578-9","journal-title":"J Neuroinflammation"},{"issue":"34","key":"6225_CR36","doi-asserted-by":"publisher","first-page":"101477","DOI":"10.1016\/j.bbrep.2023.101477","volume":"26","author":"C Mou","year":"2023","unstructured":"Mou C, Li Z, Liu N, Ni L, Xu Y (2023) Low level TGF-\u03b21-treated Umbilical mesenchymal stem cells attenuates microgliosis and neuropathic pain in chronic constriction injury by exosomes\/lncRNA UCA1\/miR-96-5p\/FOXO3a. Biochem Biophys Rep 26(34):101477. https:\/\/doi.org\/10.1016\/j.bbrep.2023.101477","journal-title":"Biochem Biophys Rep"},{"key":"6225_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bioactmat.2025.07.029","volume":"53","author":"L Zhang","year":"2025","unstructured":"Zhang L, Wang J, Liu J, Xin J, Tan Y, Zhang D, Zhu T, Zhou C (2025) TNF-\u03b1-preconditioning enhances analgesic efficacy of mesenchymal stem cell-derived extracellular vesicle in neuropathic pain via miR-101b-3p targeting Nav1.6. Bioact Mater 53:522\u2013539. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.07.029","journal-title":"Bioact Mater"},{"key":"6225_CR38","doi-asserted-by":"publisher","unstructured":"Kalvala AK, Bagde A, Arthur P, Kulkarni T, Bhattacharya S, Surapaneni S, Patel NK, Nimma R (2023) Cannabidiol-loaded extracellular vesicles from human umbilical cord mesenchymal stem cells alleviate paclitaxel-induced peripheral neuropathy. Pharmaceutics. 15(2):554. https:\/\/doi.org\/10.3390\/pharmaceutics15020554. Erratum in: Pharmaceutics. 2023 Aug 25;15(9):2200. 10.3390\/pharmaceutics15092200","DOI":"10.3390\/pharmaceutics15020554"},{"issue":"2","key":"6225_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, Chopp M, Zhang ZG, et al. (2020) Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia 63(2):431\u2013443. https:\/\/doi.org\/10.1007\/s00125-019-05043-0","journal-title":"Diabetologia"},{"issue":"1","key":"6225_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1186\/s12951-025-03678-3","volume":"23","author":"J Chen","year":"2025","unstructured":"Chen J, Zhu L, Chen Y, Liu Y, Chen W, Liu X, Yang F (2025) Targeted neural stem cell-derived extracellular vesicles loaded with Sinomenine alleviate diabetic peripheral neuropathy via WNT5a\/TRPV1 pathway modulation. J Nanobiotechnology 23(1):588. https:\/\/doi.org\/10.1186\/s12951-025-03678-3","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"6225_CR41","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.bioactmat.2021.01.008","volume":"6","author":"A Singh","year":"2021","unstructured":"Singh A, Raghav A, Shiekh PA, Kumar A (2021) Transplantation of engineered exosomes derived from bone marrow mesenchymal stromal cells ameliorate diabetic peripheral neuropathy under electrical stimulation. Bioact Mater 6(8):2231\u20132249. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.01.008","journal-title":"Bioact Mater"},{"issue":"1","key":"6225_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13287-024-03758-5","volume":"15","author":"R Poongodi","year":"2024","unstructured":"Poongodi R, Yang TH, Huang YH, Yang KD, Chen HZ, Chu TY, Wang TY, Lin HC, et al. (2024) Stem cell exosome-loaded Gelfoam improves locomotor dysfunction and neuropathic pain in a rat model of spinal cord injury. Stem Cell Res Ther 15(1):143. https:\/\/doi.org\/10.1186\/s13287-024-03758-5","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"6225_CR43","doi-asserted-by":"publisher","first-page":"E851","DOI":"10.36076\/ppj.2023.26.E851","volume":"26","author":"R Paicius","year":"2023","unstructured":"Paicius R, White ZS, Smith C, Lightner AL, Ransom JT, Lee DW, Speare S (2023) Safety and efficacy of intravenous ExoFlo in the treatment of complex regional pain syndrome. Pain Physician 26(7):E851\u2013E857","journal-title":"Pain Physician"},{"issue":"26","key":"6225_CR44","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bioactmat.2023.02.024","volume":"4","author":"Q Yang","year":"2023","unstructured":"Yang Q, Su S, Liu S, Yang S, Xu J, Zhong Y, Yang Y, Tian L, et al. (2023) Exosomes-loaded electroconductive nerve dressing for nerve regeneration and pain relief against diabetic peripheral nerve injury. Bioact Mater 4(26):194\u2013215. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.02.024","journal-title":"Bioact Mater"},{"issue":"12","key":"6225_CR45","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1007\/s12031-022-02091-x","volume":"72","author":"L Shan","year":"2022","unstructured":"Shan L, Zhan F, Lin D, Feng F, Chen X, Li X, Yang D (2022) SIRT1-enriched exosomes derived from bone marrow mesenchymal stromal cells alleviate peripheral neuropathy via conserving mitochondrial function. J Mol Neurosci 72(12):2507\u20132516. https:\/\/doi.org\/10.1007\/s12031-022-02091-x","journal-title":"J Mol Neurosci"},{"issue":"7","key":"6225_CR46","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1007\/s12035-021-02324-x","volume":"58","author":"N Fayazi","year":"2021","unstructured":"Fayazi N, Sheykhhasan M, Soleimani Asl S, Najafi R (2021) Stem cell-derived exosomes: a new strategy of neurodegenerative disease treatment. Mol Neurobiol 58(7):3494\u20133514. https:\/\/doi.org\/10.1007\/s12035-021-02324-x","journal-title":"Mol Neurobiol"},{"issue":"Pt 2","key":"6225_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.130728","volume":"264","author":"G Singh","year":"2024","unstructured":"Singh G, Mehra A, Arora S, Gugulothu D, Vora LK, Prasad R, Khatri DK (2024) Exosome-mediated delivery and regulation in neurological disease progression. Int J Biol Macromol 264(Pt 2):130728. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.130728","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"6225_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10571-024-01460-x","volume":"44","author":"Y Ge","year":"2024","unstructured":"Ge Y, Wu J, Zhang L, Huang N, Luo Y (2024) A New Strategy for the Regulation of Neuroinflammation: Exosomes Derived from Mesenchymal Stem Cells. Cell Mol Neurobiol 44(1):24. https:\/\/doi.org\/10.1007\/s10571-024-01460-x","journal-title":"Cell Mol Neurobiol"},{"issue":"18","key":"6225_CR49","doi-asserted-by":"publisher","first-page":"1679721","DOI":"10.3389\/fnmol.2025.1679721","volume":"29","author":"S Neumann","year":"2025","unstructured":"Neumann S, Sharma A, Maciaczyk J (2025) Editorial: Insights into molecular and cellular mechanisms of chronic pain and neuroinflammation. Front Mol Neurosci 29(18):1679721. https:\/\/doi.org\/10.3389\/fnmol.2025.1679721","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"6225_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010058","volume":"14","author":"A McKenzie","year":"2025","unstructured":"McKenzie A, Dombrower R, Theeraphapphong N, McKenzie S, Hijazin MA (2025) Glial activation, neuroinflammation, and loss of neuroprotection in chronic pain: cellular mechanisms and emerging therapeutic strategies. Biomedicines 14(1):58. https:\/\/doi.org\/10.3390\/biomedicines14010058","journal-title":"Biomedicines"},{"issue":"11","key":"6225_CR51","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/cells15110962","volume":"15","author":"MS Khan","year":"2026","unstructured":"Khan MS, Zafar I, Noman M, Yang G, Kang KS, Bopassa JC (2026) Polypharmacology of Pathway Crosstalk in Neurodegenerative Diseases: Chemical Modulation of Interconnected Signaling Networks. Cells 15(11):962. https:\/\/doi.org\/10.3390\/cells15110962","journal-title":"Cells"},{"key":"6225_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2025.1711454","volume":"19","author":"Y Shi","year":"2026","unstructured":"Shi Y, Li Z, Pu Y, Wang Q, Cui Z, Qi L, Sun Y (2026) The potential mechanisms and regulatory roles of exosomal miRNA in neural repair after spinal cord injury. Front Cell Neurosci 19:1711454. https:\/\/doi.org\/10.3389\/fncel.2025.1711454","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"6225_CR53","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3390\/ph19050692","volume":"19","author":"FAZ Liongson","year":"2026","unstructured":"Liongson FAZ, Yoo J, Swett B, Falowski SM, Pope JE, Sayed D, Deer TE, Hasoon JJ, et al. (2026) Regenerative Medicine Approaches to Craniofacial and Corneal Neuropathic Pain. Pharmaceuticals (Basel) 19(5):692. https:\/\/doi.org\/10.3390\/ph19050692","journal-title":"Pharmaceuticals (Basel)"},{"issue":"7","key":"6225_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167960","volume":"1871","author":"Z Deng","year":"2025","unstructured":"Deng Z, Chen H, Chen J, Du Z, Zhou W, Yuan Z (2025) Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases. Biochim Biophys Acta Mol Basis Dis 1871(7):167960. https:\/\/doi.org\/10.1016\/j.bbadis.2025.167960","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"6225_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-026-01720-y","volume":"46","author":"DH Bach","year":"2026","unstructured":"Bach DH, Van Giang B, Nguyen TL (2026) Cell therapy for spinal cord injury: mechanistic insights and translational challenges. Cell Mol Neurobiol 46(1):91. https:\/\/doi.org\/10.1007\/s10571-026-01720-y","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"6225_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14020414","volume":"14","author":"Y Wen","year":"2026","unstructured":"Wen Y, Zhang R, Wang J, Ma Z, Dong C, Li R, Zhang J (2026) Exosomes: roles and therapeutic potential in pain. Biomedicines 14(2):414. https:\/\/doi.org\/10.3390\/biomedicines14020414","journal-title":"Biomedicines"},{"issue":"1","key":"6225_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s43556-025-00277-4","volume":"6","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wang H, Tan J, Cao Z, Wang Q, Wang H, Yue S, Li W, et al. (2025) Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases. Mol Biomed 6(1):34. https:\/\/doi.org\/10.1186\/s43556-025-00277-4","journal-title":"Mol Biomed"},{"issue":"12","key":"6225_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26125447","volume":"26","author":"J Sankaranarayanan","year":"2025","unstructured":"Sankaranarayanan J, Kim HK, Kang JY, Kuppa SS, Yang HY, Seon JK (2025) Comparative efficacy of exosomes derived from different mesenchymal stem cell sources in osteoarthritis models: an in vitro and ex vivo analysis. Int J Mol Sci 26(12):5447. https:\/\/doi.org\/10.3390\/ijms26125447","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6225_CR59","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/j.pain.0000000000003425","volume":"166","author":"J Yang","year":"2025","unstructured":"Yang J, Xie YF, Smith R, Ratt\u00e9 S, Prescott SA (2025) Discordance between preclinical and clinical testing of Na V 1.7-selective inhibitors for pain. Pain 166(3):481\u2013501. https:\/\/doi.org\/10.1097\/j.pain.0000000000003425","journal-title":"Pain"},{"issue":"9","key":"6225_CR60","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.3390\/jcm12093181","volume":"12","author":"I S\u00e1nchez-Iglesias","year":"2023","unstructured":"S\u00e1nchez-Iglesias I, Mart\u00edn-Aguilar C (2023) Significant Differences and Experimental Designs Do Not Necessarily Imply Clinical Relevance: Effect Sizes and Causality Claims in Antidepressant Treatments. J Clin Med 12(9):3181. https:\/\/doi.org\/10.3390\/jcm12093181","journal-title":"J Clin Med"},{"issue":"6","key":"6225_CR61","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.85448","volume":"17","author":"S Bashir","year":"2025","unstructured":"Bashir S (2025) Clinical assessment of abrocitinib, tofacitinib, and cyclosporine in adult patients with moderate to severe atopic dermatitis: a retrospective analysis. Cureus 17(6):e85448. https:\/\/doi.org\/10.7759\/cureus.85448","journal-title":"Cureus"},{"issue":"6","key":"6225_CR62","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/01410768221100970","volume":"115","author":"M Ritskes-Hoitinga","year":"2022","unstructured":"Ritskes-Hoitinga M, Pound P (2022) The role of systematic reviews in identifying the limitations of preclinical animal research, 2000-2022: part 2. J R Soc Med 115(6):231\u2013235. https:\/\/doi.org\/10.1177\/01410768221100970","journal-title":"J R Soc Med"},{"issue":"11","key":"6225_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275962","volume":"17","author":"BS Kousholt","year":"2022","unstructured":"Kousholt BS, Pr\u00e6stegaard KF, Stone JC, Thomsen AF, Johansen TT, Ritskes-Hoitinga M, Wegener G (2022) Reporting quality in preclinical animal experimental research in 2009 and 2018: a nationwide systematic investigation. PLoS ONE 17(11):e0275962. https:\/\/doi.org\/10.1371\/journal.pone.0275962","journal-title":"PLoS ONE"},{"issue":"26","key":"6225_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202521913","volume":"13","author":"DJ Lundy","year":"2026","unstructured":"Lundy DJ, Chau ZL, Chen SY, Fujisawa N, Hill JJ, Hsu BM, Liu JK, Mai KW, et al. (2026) Beyond extracellular vesicle (EV) hype: practical solutions and remaining hurdles in EV research, manufacturing, and clinical translation. Adv Sci (Weinh) 13(26):e21913. https:\/\/doi.org\/10.1002\/advs.202521913","journal-title":"Adv Sci (Weinh)"},{"key":"6225_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1626085","volume":"16","author":"LA Pikor","year":"2025","unstructured":"Pikor LA, Arivazhagan S, Mendicino M, Sathiamoorthy S (2025) Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy. Front Immunol 16:1626085. https:\/\/doi.org\/10.3389\/fimmu.2025.1626085","journal-title":"Front Immunol"},{"key":"6225_CR66","doi-asserted-by":"publisher","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, Carreira B, Pozzi S, Ac\u00farcio RC, Satchi-Fainaro R, Florindo HF, et al (2022) Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res Mar 12(3):500\u2013525. https:\/\/doi.org\/10.1007\/s13346-021-01024-2","DOI":"10.1007\/s13346-021-01024-2"},{"issue":"4","key":"6225_CR67","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/biom.13342","volume":"76","author":"C Hong","year":"2020","unstructured":"Hong C, Salanti G, Morton SC, Riley RD, Chu H, Kimmel SE, Chen Y (2020) Testing small study effects in multivariate meta-analysis. Biometrics 76(4):1240\u20131250. https:\/\/doi.org\/10.1111\/biom.13342","journal-title":"Biometrics"},{"issue":"1","key":"6225_CR68","doi-asserted-by":"publisher","first-page":"545","DOI":"10.7150\/thno.117143","volume":"16","author":"Q Huang","year":"2026","unstructured":"Huang Q, Wang S, Liu Z, Rao L, Cheng K, Mao X (2026) Engineering exosomes for targeted neurodegenerative therapy: innovations in biogenesis, drug loading, and clinical translation. Theranostics 16(1):545\u2013579. https:\/\/doi.org\/10.7150\/thno.117143","journal-title":"Theranostics"},{"issue":"7","key":"6225_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26073137","volume":"26","author":"EC Lee","year":"2025","unstructured":"Lee EC, Choi D, Lee DH, Oh JS (2025) Engineering exosomes for CNS disorders: advances, challenges, and therapeutic potential. Int J Mol Sci 26(7):3137. https:\/\/doi.org\/10.3390\/ijms26073137","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6225_CR70","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-025-01661-y","volume":"46","author":"A Yadegari","year":"2026","unstructured":"Yadegari A, Tahmasebi F, Asl ER, Vahidinia Z, Barati S (2026) Dual-targeting miR-219 and miR-146a in multiple sclerosis: bridging myelin repair and neuroinflammation for novel therapeutic insights. Cell Mol Neurobiol 46(1):22. https:\/\/doi.org\/10.1007\/s10571-025-01661-y","journal-title":"Cell Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06225-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06225-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:30:47Z","timestamp":1791271847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06225-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6225"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06225-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This paper is submitted with the agreement of all its co-authors and the author list has been approved by all authors.","order":5,"name":"Ethics","label":"Author Agreement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Clinical Trial","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"950"}}